MyFinsight
Home
About
Contact
pvct: the income statement
Download
Download image
Net loss
attributable to common...
-$1,311,281
(-29.27%↓ Y/Y)
Net loss
attributable to...
-$12,348
Net loss
-$1,323,629
(-30.49%↓ Y/Y)
Total other income
(expense), net
-$48,022
Total operating loss
-$1,275,607
(-33.47%↓ Y/Y)
Interest expense
-$48,022
(18.16%↑ Y/Y)
Total operating
expenses
$1,275,607
(19.72%↑ Y/Y)
General and
administrative
$929,746
(42.71%↑ Y/Y)
Research and development
$345,861
(-16.46%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)